Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2026
The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lavoignet-Cisneros Michelle, Alberto-López Lidia Joanna, Viveros-Lugo Miguel Ángel, Couriel Daniel, Robles-Nasta Max, Chávez-Martínez Sofía, Salgado-Cabrera Monica Daniela, Olivares-Gazca Juan Carlos, Ruiz-Delgado Guillermo José, Ruiz-Argüelles Guillermo José
Аннотация
BACKGROUND: Bacterial cultures of apheresis products are mandated by FACT-JACIE standards as a safety measure in autologous hematopoietic stem cell transplantation (aHSCT). However, results are often available only after reinfusion, raising questions about their clinical utility, particularly in programs that use fresh, non-cryopreserved products.
OBJECTIVE: To evaluate the incidence, microbiological profile, and clinical relevance of positive bacterial cultures in apheresis products used for aHSCT in autoimmune diseases.
METHODS: This prospective study included 629 apheresis products administered to 586 patients with MS or CIDP who underwent outpatient, non-cryopreserved aHSCT between July 2021 and March 2025. Bacterial cultures were performed from product aliquots using the BACTEC system (aerobic and anaerobic bottles). Positive isolates underwent antibiotic susceptibility testing. Culture results, timing of positivity, and 28-day post-infusion outcomes were analyzed.
RESULTS: Bacterial contamination was detected in 8 of 629 products (1.3 %). In one case, Escherichia coli was isolated within 24 h, leading to identification of a urinary tract infection and fatal sepsis in the patient; the contaminated product was discarded. The remaining seven cases became positive after 2-11 days (median: 6), when products had already been infused. Isolates included Cutibacterium acnes (n = 6), Staphylococcus capitis (n = 1), and Coryneform bacteria (n = 1). All were considered contamination during aliquot handling. No clinical complications occurred in these patients during the 28-day follow-up.
CONCLUSION: Routine bacterial cultures of apheresis products yielded clinically relevant information in only 1 of 629 procedures. Most positive results reflected contamination of aliquots rather than true product infection, suggesting that the value of routine cultures in fresh aHSCT for autoimmune diseases may be limited and warrants re-evaluation.
OBJECTIVE: To evaluate the incidence, microbiological profile, and clinical relevance of positive bacterial cultures in apheresis products used for aHSCT in autoimmune diseases.
METHODS: This prospective study included 629 apheresis products administered to 586 patients with MS or CIDP who underwent outpatient, non-cryopreserved aHSCT between July 2021 and March 2025. Bacterial cultures were performed from product aliquots using the BACTEC system (aerobic and anaerobic bottles). Positive isolates underwent antibiotic susceptibility testing. Culture results, timing of positivity, and 28-day post-infusion outcomes were analyzed.
RESULTS: Bacterial contamination was detected in 8 of 629 products (1.3 %). In one case, Escherichia coli was isolated within 24 h, leading to identification of a urinary tract infection and fatal sepsis in the patient; the contaminated product was discarded. The remaining seven cases became positive after 2-11 days (median: 6), when products had already been infused. Isolates included Cutibacterium acnes (n = 6), Staphylococcus capitis (n = 1), and Coryneform bacteria (n = 1). All were considered contamination during aliquot handling. No clinical complications occurred in these patients during the 28-day follow-up.
CONCLUSION: Routine bacterial cultures of apheresis products yielded clinically relevant information in only 1 of 629 procedures. Most positive results reflected contamination of aliquots rather than true product infection, suggesting that the value of routine cultures in fresh aHSCT for autoimmune diseases may be limited and warrants re-evaluation.